Charles MELANCON,Pamela HALL,Jacob GREENBERG,Yasushi OGASAWARA,Snezna ROGELJ
申请号：
US15552541
公开号：
US20180050050A1
申请日:
2016.02.23
申请国别(地区):
US
年份:
2018
代理人:
摘要：
In one aspect, this disclosure describes a pharmaceutical composition that generally includes frankiamicin A and a pharmaceutically acceptable carrier. In another aspect, this disclosure describes a method of treating a subject having, or at risk of having, a condition caused by a microbial infection treatable with frankiamicin A. Generally, the method includes administering to the subject an amount of frankiamicin A effective to ameliorate at least one symptom or clinical sign of the condition.
